These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Kuismanen SA; Holmberg MT; Salovaara R; de la Chapelle A; Peltomäki P Am J Pathol; 2000 May; 156(5):1773-9. PubMed ID: 10793088 [TBL] [Abstract][Full Text] [Related]
44. The association between methylenetetrahydrofolate reductase polymorphism and promoter methylation in proximal colon cancer. Oyama K; Kawakami K; Maeda K; Ishiguro K; Watanabe G Anticancer Res; 2004; 24(2B):649-54. PubMed ID: 15161007 [TBL] [Abstract][Full Text] [Related]
45. A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Lind GE; Thorstensen L; Løvig T; Meling GI; Hamelin R; Rognum TO; Esteller M; Lothe RA Mol Cancer; 2004 Oct; 3():28. PubMed ID: 15476557 [TBL] [Abstract][Full Text] [Related]
46. Methylation profile of the MLH1 promoter region and their relationship to colorectal carcinogenesis. Miyakura Y; Sugano K; Konishi F; Fukayama N; Igarashi S; Kotake K; Matsui T; Koyama Y; Maekawa M; Nagai H Genes Chromosomes Cancer; 2003 Jan; 36(1):17-25. PubMed ID: 12461746 [TBL] [Abstract][Full Text] [Related]
47. Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer. Fox EJ; Leahy DT; Geraghty R; Mulcahy HE; Fennelly D; Hyland JM; O'Donoghue DP; Sheahan K J Mol Diagn; 2006 Feb; 8(1):68-75. PubMed ID: 16436636 [TBL] [Abstract][Full Text] [Related]
48. Methylation status and expression of human telomerase reverse transcriptase mRNA in relation to hypermethylation of the p16 gene in colorectal cancers as analyzed by bisulfite PCR-SSCP. Nomoto K; Maekawa M; Sugano K; Ushiama M; Fukayama N; Fujita S; Kakizoe T Jpn J Clin Oncol; 2002 Jan; 32(1):3-8. PubMed ID: 11932355 [TBL] [Abstract][Full Text] [Related]
50. Promoter methylation of specific genes is associated with the phenotype and progression of colorectal adenocarcinomas. Kim JC; Choi JS; Roh SA; Cho DH; Kim TW; Kim YS Ann Surg Oncol; 2010 Jul; 17(7):1767-76. PubMed ID: 20077021 [TBL] [Abstract][Full Text] [Related]
51. The role of DNA hypermethylation in human neoplasia. Toyota M; Issa JP Electrophoresis; 2000 Jan; 21(2):329-33. PubMed ID: 10675010 [TBL] [Abstract][Full Text] [Related]
52. CpG island methylation is a common finding in colorectal cancer cell lines. Suter CM; Norrie M; Ku SL; Cheong KF; Tomlinson I; Ward RL Br J Cancer; 2003 Feb; 88(3):413-9. PubMed ID: 12569385 [TBL] [Abstract][Full Text] [Related]
53. Molecular dissection of premalignant colorectal lesions reveals early onset of the CpG island methylator phenotype. Yamamoto E; Suzuki H; Yamano HO; Maruyama R; Nojima M; Kamimae S; Sawada T; Ashida M; Yoshikawa K; Kimura T; Takagi R; Harada T; Suzuki R; Sato A; Kai M; Sasaki Y; Tokino T; Sugai T; Imai K; Shinomura Y; Toyota M Am J Pathol; 2012 Nov; 181(5):1847-61. PubMed ID: 22995252 [TBL] [Abstract][Full Text] [Related]
54. Causes and consequences of microsatellite instability in endometrial carcinoma. Gurin CC; Federici MG; Kang L; Boyd J Cancer Res; 1999 Jan; 59(2):462-6. PubMed ID: 9927063 [TBL] [Abstract][Full Text] [Related]
55. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Leung SY; Yuen ST; Chung LP; Chu KM; Chan AS; Ho JC Cancer Res; 1999 Jan; 59(1):159-64. PubMed ID: 9892201 [TBL] [Abstract][Full Text] [Related]
56. Colorectal cancer without high microsatellite instability and chromosomal instability--an alternative genetic pathway to human colorectal cancer. Tang R; Changchien CR; Wu MC; Fan CW; Liu KW; Chen JS; Chien HT; Hsieh LL Carcinogenesis; 2004 May; 25(5):841-6. PubMed ID: 14729584 [TBL] [Abstract][Full Text] [Related]
57. IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype. Suzuki H; Igarashi S; Nojima M; Maruyama R; Yamamoto E; Kai M; Akashi H; Watanabe Y; Yamamoto H; Sasaki Y; Itoh F; Imai K; Sugai T; Shen L; Issa JP; Shinomura Y; Tokino T; Toyota M Carcinogenesis; 2010 Mar; 31(3):342-9. PubMed ID: 19638426 [TBL] [Abstract][Full Text] [Related]
58. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene. Shin KH; Shin JH; Kim JH; Park JG Cancer Res; 2002 Jan; 62(1):38-42. PubMed ID: 11782355 [TBL] [Abstract][Full Text] [Related]
59. Methylation in hMLH1 promoter interferes with its binding to transcription factor CBF and inhibits gene expression. Deng G; Chen A; Pong E; Kim YS Oncogene; 2001 Oct; 20(48):7120-7. PubMed ID: 11704838 [TBL] [Abstract][Full Text] [Related]
60. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas. Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]